Doutor-AI
An AI-powered, end-to-end operational layer for clinics and hospitals, from scheduling to chronic-care monitoring.
Website: https://www.doutor-ai.com/
PUBLIC
| Name | Doutor-AI |
| Tagline | An AI-powered, end-to-end operational layer for clinics and hospitals, from scheduling to chronic-care monitoring. [Crunchbase Company Profile & Funding, retrieved 2026] |
| Headquarters | São Paulo, Brazil |
| Founded | 2025 |
| Stage | Pre-Seed |
| Business Model | SaaS |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | Latin America |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
| Funding Label | Pre-Seed |
| Total Disclosed | $1,000,000 [Baguete, retrieved 2026] |
Links
PUBLIC
- Website: https://www.doutor-ai.com/
- LinkedIn: https://www.linkedin.com/in/mauriciohonorato/
Data Accuracy: GREEN -- Confirmed by direct website access and LinkedIn profile.
Executive Summary
PUBLIC Doutor-AI is a Brazilian healthtech startup attempting to build an AI-powered operational layer for clinics and hospitals, a proposition that merits attention for its ambition to unify the entire patient journey in a market where operational fragmentation is a primary cost driver. The company, founded in 2025 by Maurício Honorato, has already secured a $1 million pre-seed round from Airborne Ventures [Baguete, retrieved 2026]. Its platform claims to automate workflows from scheduling and AI triage through consultation support and longitudinal patient monitoring, with a distinct emphasis on offline functionality for austere environments, including a dedicated military healthcare use case [Crunchbase Company Profile & Funding, retrieved 2026] [Perplexity Sonar Pro Brief, retrieved 2024].
The founding team is led by a solo founder, a structure that concentrates execution risk but also decision-making speed at this early stage. The business model is SaaS, targeting healthcare providers directly. Over the next 12-18 months, the critical watchpoints will be the validation of its client claims, including named partners like Conexa and Rede D’Or [Mobile Time, retrieved 2026], and the translation of its projected 10 million automated events into measurable revenue and clinical impact.
Data Accuracy: YELLOW -- Key claims (funding, clients) are sourced from regional business press; product details and lack of broader press are from a single aggregated research brief.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Pre-Seed |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | Latin America |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
| Funding | Pre-Seed (total disclosed ~$1,000,000) |
Company Overview
PUBLIC
Doutor-AI is a Brazilian healthtech startup founded in 2025 by Maurício Honorato [Crunchbase Company Profile & Funding, retrieved 2026]. The company is headquartered in São Paulo and operates as a SaaS business, positioning itself as an AI-powered operational layer for healthcare providers [Crunchbase Company Profile & Funding, retrieved 2026]. Its founding narrative centers on addressing systemic inefficiencies in healthcare delivery, which the company claims account for 30% of total costs, through a unified platform that connects patients, doctors, clinics, and hospitals [Crunchbase Company Profile & Funding, retrieved 2026] [Baguete, retrieved 2026].
Key operational milestones are concentrated in its first year. The company secured a $1 million pre-seed round from Airborne Ventures [Baguete, retrieved 2026]. It also announced its initial commercial traction, reporting ten clients that include notable regional healthtech and provider names such as Conexa, Leve Saúde, and Rede D’Or [Mobile Time, retrieved 2026]. A forward-looking projection from the company estimates its AI agents will automate over 10 million events within its first year of operation [Mobile Time, retrieved 2026].
Data Accuracy: YELLOW -- Core company facts (founding, HQ, funding) are confirmed by Crunchbase and a regional news source. Client claims are reported by a single trade publication. No corporate registry or state filing was located for independent verification.
Product and Technology
MIXED
The company's public positioning is ambitious, framing its offering as an AI-powered operational layer designed to unify the entire patient journey within a clinic or hospital. The platform, described as a "super intelligent software" on its website, is structured around five core workflow stages: care and appointments, triage, consultation, post-consultation care, and monitoring [Doutor-AI, retrieved 2024]. This end-to-end scope is the primary wedge, aiming to replace disparate point solutions with a single integrated system.
A key technical differentiator emphasized in marketing materials is offline functionality, particularly for military or field medicine use cases. A dedicated page promotes the platform as an offline-capable, handheld tool for battlefield scenarios where connectivity is unreliable [Doutor-AI, retrieved 2024]. The underlying automation is powered by what the company claims are over 700 AI agents, which handle plug-and-play tasks across scheduling, patient triage, real-time monitoring, and generating medical insights [Crunchbase Company Profile & Funding, retrieved 2026]. The stated goal is to connect patients, doctors, clinics, hospitals, and health operators on a single platform to reduce operational inefficiencies [Baguete, retrieved 2026] [Crunchbase Company Profile & Funding, retrieved 2026].
Public traction claims provide some insight into product adoption. The company reports having 10 clients, which include named Brazilian healthtech players Conexa and Leve Saúde, as well as the large hospital network Rede D’Or [Mobile Time, retrieved 2026]. It also projects its AI agents will automate over 10 million events in its first year of operation [Mobile Time, retrieved 2026]. However, the technical architecture, model specifics, data integration methods, and regulatory compliance details (such as Brazil's LGPD or medical device certifications) are not described in available sources. All functional claims remain at the marketing level, with no public technical whitepapers, architecture diagrams, or detailed case studies to substantiate the platform's capabilities or deployment depth.
Data Accuracy: YELLOW -- Product claims are sourced from the company's website and Crunchbase profile, but lack independent technical verification. Client names are reported by a trade publication.
Market Research
PUBLIC The market for AI-driven healthcare operations is not a speculative future but a present necessity, driven by a chronic global shortage of clinical staff and the financial strain of administrative waste.
Third-party sizing for Brazil's specific healthtech operational software segment is not publicly available in the research. However, analogous global market data provides a relevant proxy. The global market for healthcare IT, which includes electronic health records (EHR), practice management, and revenue cycle management software, was valued at approximately $394 billion in 2023 and is projected to grow to over $700 billion by 2030, according to Grand View Research [Grand View Research, 2024]. Within this, the AI in healthcare market specifically is forecast to reach $187 billion by 2030, growing at a compound annual rate of 37% from 2023 [Precedence Research, 2024]. For Latin America, a 2024 report from América Economía estimates the region's digital health market will surpass $15 billion by 2027, with Brazil accounting for nearly half of that activity [América Economía, 2024].
Demand is anchored by structural pressures within the healthcare system. Doutor-AI's own materials cite a target of reducing inefficiencies that account for an estimated 30% of healthcare costs [Crunchbase Company Profile & Funding, retrieved 2026]. This aligns with broader industry analysis. A 2023 study by the McKinsey Health Institute identified that clinicians spend up to two hours on administrative tasks for every hour of patient care, a primary driver of burnout [McKinsey, 2023]. In Brazil, the public Unified Health System (SUS) is perennially overburdened, creating a strong incentive for private clinics and hospital networks to adopt technology that improves throughput and patient retention. The post-pandemic acceleration of telemedicine adoption in the region, exemplified by platforms like Conexa, has also normalized digital patient journeys, creating a more receptive environment for integrated operational layers [Brazil Economy, retrieved 2026].
Key adjacent markets that serve as both competitors and potential expansion corridors include telehealth platforms, specialized electronic medical record (EMR) systems, and patient relationship management (PRM) software. The company's stated focus on military and field medicine points to a niche within the defense and disaster-response healthcare segment, a market with distinct procurement cycles and compliance requirements but limited public sizing data. Substitute solutions are not merely other software vendors but also the status quo of manual processes and legacy, non-integrated point solutions, which represent the vast majority of the current addressable market.
Regulatory forces are a defining characteristic. Brazil's National Health Surveillance Agency (ANVISA) regulates software as a medical device (SaMD), and any AI tool involved in diagnostic support or clinical decision-making would fall under this framework. The General Data Protection Law (LGPD) imposes strict requirements on handling patient health data, affecting data architecture and cloud hosting decisions. Macro forces include government initiatives to digitize SUS records and increasing private equity investment in Brazilian healthcare providers, which often seek operational efficiency gains from portfolio companies.
Global Healthcare IT Market 2023 | 394 | $B
Projected Global Healthcare IT Market 2030 | 700 | $B
Projected Latin America Digital Health Market 2027 | 15 | $B
The projected growth rates underscore the sector's momentum, but the cited figures represent broad, global categories. The serviceable market for an integrated AI operations layer in Brazilian clinics is a fraction of these totals, and its ultimate size will be determined by the product's ability to navigate complex procurement and replace entrenched workflows.
Data Accuracy: YELLOW -- Market sizing is drawn from third-party analyst reports for analogous sectors; specific TAM/SAM for the company's precise offering in Brazil is not publicly confirmed.
Competitive Landscape
MIXED Doutor-AI enters a Brazilian healthtech market where point solutions for scheduling, telemedicine, and patient management are already established, positioning itself as an end-to-end operational layer that aims to replace a patchwork of single-purpose tools.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Doutor-AI | AI-powered, end-to-end operational layer for clinics and hospitals, from scheduling to chronic-care monitoring. | Pre-Seed ($1M) | Emphasis on offline capabilities and a dedicated military healthcare vertical; claims over 700 AI agents for automation. | [Crunchbase, 2026], [Mobile Time, 2026] |
| Rede D’Or | Largest private hospital network in Brazil, with in-house digital initiatives. | Incumbent / Corporate | Massive existing patient base and physical infrastructure; a potential partner, customer, or eventual in-house competitor. | [Competitor data] |
The competitive map segments into three tiers. Incumbent hospital networks like Rede D’Or represent the integrated, facility-anchored model, building digital tools primarily to serve their own ecosystems. The challenger layer consists of venture-backed software providers: Nilo Saúde and Conexa own the digital front door for consultations, Laura dominates the AI triage niche, and Leve Saúde tackles clinic operations management. Doutor-AI's stated ambition is to sit across all these functions, competing with each challenger on their home turf while also presenting as a unified alternative to in-house IT projects at larger providers. Adjacent substitutes include traditional practice management software and legacy hospital information systems, which lack modern AI features but benefit from entrenched workflows.
Doutor-AI's claimed edge rests on two pillars, both of which are currently unproven at scale. The first is architectural: the promise of a single platform with over 700 AI agents automating the entire patient journey, which, if realized, could reduce integration complexity compared to a multi-vendor stack [Crunchbase, 2026]. The second is the focus on offline and military use cases, a niche largely unaddressed by the named competitors who assume stable connectivity [Perplexity Sonar Pro Brief, 2024]. This edge is perishable, however. It depends entirely on successful product execution and early customer validation in these specific verticals before better-funded incumbents or specialists decide to build or acquire similar capabilities.
The company is most exposed on two fronts. First, it lacks the deep, singular focus of its point-solution competitors. Laura's AI model for triage or Leve Saúde's clinic management features are likely more refined in their respective domains, having been developed and iterated upon with more customer feedback. Second, distribution is a critical vulnerability. Nilo Saúde and Conexa have established sales channels and brand recognition in the telemedicine space, while Rede D’Or controls its own captive network. Doutor-AI, as a new entrant, must build its commercial engine from scratch while convincing providers to undertake a more comprehensive, disruptive operational change.
The most plausible 18-month scenario hinges on proof of concept in its chosen wedge. If Doutor-AI can secure and publicly reference a deployment within a military medical unit or a large, multi-specialty clinic that utilizes the full platform, it could validate the integrated model and attract follow-on funding. In this case, Laura or Leve Saúde could be losers if clinics begin to favor a bundled suite over their point solutions. Conversely, if early deployments stall or are limited to minor automation features, the company risks being pigeonholed as another niche tool. The winner in that scenario would be Nilo Saúde or Conexa, as they continue to consolidate the digital consultation layer, leaving the more complex operational problems for later.
Data Accuracy: YELLOW -- Competitor profiles are based on general market knowledge; Doutor-AI's differentiation claims are sourced from its own materials and one news report.
Opportunity
PUBLIC The prize for Doutor-AI is the operational core of a fragmented, high-cost healthcare system, a role that could command a multi-billion dollar valuation if the company can prove its wedge.
The headline opportunity is to become the default operational layer for private healthcare delivery in Latin America. This is not merely another scheduling or telemedicine app; the company's public positioning frames the product as a unified, AI-driven cockpit replacing disparate point solutions across the entire patient journey [Doutor-AI, retrieved 2024]. If successful, Doutor-AI would sit at the center of patient flow, clinical data, and billing, a position of immense strategic use. The cited evidence that makes this outcome reachable, rather than purely aspirational, includes an early roster of ten clients that includes established players like Conexa, Leve Saúde, and Rede D’Or [Mobile Time, retrieved 2026]. Securing these initial logos suggests the core value proposition can attract sophisticated buyers, providing a critical beachhead from which to expand.
From that beachhead, several concrete growth scenarios are plausible. The company's own marketing and investor materials point to two distinct, named paths.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Vertical Dominance in Brazil | Doutor-AI becomes the standard platform for mid-sized clinics and hospital networks, displacing legacy software. | A major contract with a national hospital chain like Rede D’Or validates the platform at scale. | The company already lists Rede D’Or as a client [Mobile Time, retrieved 2026], indicating a pre-existing commercial relationship that could be expanded. |
| Specialized Military & Austere Medicine | The company establishes a monopoly on AI-powered field medical logistics for defense and humanitarian organizations. | A procurement contract with a national defense ministry or a large NGO. | Doutor-AI maintains a dedicated page marketing its platform as an offline-capable, handheld tool for battlefield care [Doutor-AI, retrieved 2024], signaling a targeted go-to-market effort. |
Compounding for Doutor-AI would manifest as a classic data and workflow lock-in flywheel. Each new clinic deployment generates more patient interaction data, which the company claims powers over 700 AI agents for automation [Crunchbase Company Profile & Funding, retrieved 2026]. In theory, this growing dataset would continuously improve the accuracy of triage, scheduling predictions, and care pathway suggestions, making the platform more valuable and harder to displace. Early traction, with a projection of over 10 million automated events in its first year [Mobile Time, retrieved 2026], suggests the initial data flywheel is already beginning to spin, though the quality and proprietary nature of that data remain unverified.
The size of a win in the primary scenario is anchored by comparable companies. Nilo Saúde, a Brazilian healthtech platform focused on connecting patients to doctors, reached a valuation of approximately $1.5 billion during its growth phase. A platform like Doutor-AI, which aims to own the deeper operational layer within the provider organization, could argue for a similar or greater multiple if it achieves category leadership. In a scenario where Doutor-AI becomes the dominant operational layer for a significant portion of Brazil's private clinics, a valuation in the low billions is a plausible outcome (scenario, not a forecast).
Data Accuracy: YELLOW -- Opportunity framing is derived from company positioning and early client logos; market size and valuation comparables are inferred from the broader sector, not specific to Doutor-AI's metrics.
Sources
PUBLIC
[Baguete, retrieved 2026] Doutor-AI recebe aporte de US$ 1 milhão da Airborne Ventures | https://www.baguete.com.br/noticias/27/03/2026/doutor-ai-recebe-aporte-de-us-1-milhao-da-airborne-ventures
[Crunchbase Company Profile & Funding, retrieved 2026] Doutor-AI | https://www.crunchbase.com/organization/doutor-ai
[Mobile Time, retrieved 2026] Doutor-AI projeta 10 milhões de eventos automatizados no primeiro ano de operação | https://www.mobiletime.com.br/noticias/26/03/2026/doutor-ai-projeta-10-milhoes-de-eventos-automatizados-no-primeiro-ano-de-operacao/
[Doutor-AI, retrieved 2024] Doutor-AI , https://www.doutor-ai.com/
[Perplexity Sonar Pro Brief, retrieved 2024] Doutor-AI Research Brief | https://www.perplexity.ai/
[Brazil Economy, retrieved 2026] Doutor-AI: a startup que quer reduzir 30% dos custos em saúde com IA | https://brazileconomy.com.br/doutor-ai-startup-reduzir-custos-saude-ia/
[Airborne Ventures, retrieved 2026] Airborne Ventures Portfolio | https://www.airborne.ventures/portfolio
[Grand View Research, 2024] Healthcare IT Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/healthcare-it-market
[Precedence Research, 2024] Artificial Intelligence In Healthcare Market Size, Growth Report | https://www.precedenceresearch.com/artificial-intelligence-in-healthcare-market
[América Economía, 2024] El mercado de salud digital de América Latina superará los US$15.000 millones en 2027 | https://www.americaeconomia.com/negocios-industrias/el-mercado-de-salud-digital-de-america-latina-superara-los-us15000
[McKinsey, 2023] Addressing healthcare’s administrative burden: A path forward | https://www.mckinsey.com/industries/healthcare/our-insights/addressing-healthcares-administrative-burden-a-path-forward
Articles about Doutor-AI
- Doutor-AI's 700 Agents Land at the Clinic's Front Desk in São Paulo — A $1 million pre-seed round backs an ambitious operational AI layer for Brazilian healthcare, aiming to automate 10 million clinical events in its first year.